Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ciliation and mucus secretion in an in vitro model of nasal mucosa based on CI-pNaEC cell line for preclinical drug testing.

European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V·2026
Same author

Development of a human-derived bioink based on keratin methacrylate for corneal bioprinting.

Journal of applied biomaterials & functional materials·2026
Same author

Keratin-Laden Bioink for Corneal Stroma Bioprinting.

Bioengineering (Basel, Switzerland)·2026
Same author

An Overview of In Vitro Release Methods for Long-Acting Injectable Products Based on PLGA.

Methods and protocols·2026
Same author

Cortical development dynamics across autism spectrum disorder mouse models.

Nature·2026
Same author

Olanzapine for Extended-Release Injectable Suspension for Subcutaneous Use (TV-44749) Designed to Avoid the Risk of PDSS: In Vitro Release Studies in Human Plasma and In Vivo Impact of Extrinsic Factors on Pharmacokinetics.

Pharmaceutics·2026
Same journal

Design and Process Parameter Evaluation of Bilayer Capsule Systems for Targeted Ileal Drug Delivery.

European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences·2026
Same journal

iRGD-Modified Peptide-Drug Conjugate Improves Brain Delivery and Antitumor Efficacy in Glioblastoma.

European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences·2026
Same journal

A Δ‑Based Framework For Internal Release Limits In Plateau Stability Systems.

European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences·2026
Same journal

Innovative Peptide Formulations for Cardiovascular Diseases Using Supercritical CO<sub>2</sub>: A Comprehensive Review and Potential Applications.

European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences·2026
Same journal

An injectable nanoreinforced hydrogel for combined GDNF-loaded nanoparticles and mesenchymal stem cell therapy in Parkinson's disease.

European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences·2026
Same journal

Lipid nanoparticles for Cas9 ribonucleoprotein delivery: design and evaluation of ionisable oligoamine-lipidoids.

European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences·2026
See all related articles

Related Experiment Video

Updated: Mar 6, 2026

Lucifer Yellow - A Robust Paracellular Permeability Marker in a Cell Model of the Human Blood-brain Barrier
06:22

Lucifer Yellow - A Robust Paracellular Permeability Marker in a Cell Model of the Human Blood-brain Barrier

Published on: August 19, 2019

25.7K

HCE-T cell-based permeability model: A well-maintained or a highly variable barrier phenotype?

Marina Juretić1, Bisera Jurišić Dukovski1, Iva Krtalić2

  • 1University of Zagreb, Faculty of Pharmacy and Biochemistry, Department of Pharmaceutical Technology, A. Kovačića 1, 10000 Zagreb, Croatia.

European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|March 19, 2017
PubMed
Summary
This summary is machine-generated.

The immortalized human corneal epithelial (HCE-T) cell line shows varied barrier phenotypes based on cultivation. Model II, using larger pore membranes, better predicts transcorneal drug permeation.

Keywords:
Barrier propertiesCorneaDrug permeabilityIn vitro/ex vivo correlationOcular delivery

More Related Videos

Models and Methods to Evaluate Transport of Drug Delivery Systems Across Cellular Barriers
18:57

Models and Methods to Evaluate Transport of Drug Delivery Systems Across Cellular Barriers

Published on: October 17, 2013

47.5K
A Choroid Plexus Epithelial Cell-based Model of the Human Blood-Cerebrospinal Fluid Barrier to Study Bacterial Infection from the Basolateral Side
09:58

A Choroid Plexus Epithelial Cell-based Model of the Human Blood-Cerebrospinal Fluid Barrier to Study Bacterial Infection from the Basolateral Side

Published on: May 6, 2016

15.0K

Related Experiment Videos

Last Updated: Mar 6, 2026

Lucifer Yellow - A Robust Paracellular Permeability Marker in a Cell Model of the Human Blood-brain Barrier
06:22

Lucifer Yellow - A Robust Paracellular Permeability Marker in a Cell Model of the Human Blood-brain Barrier

Published on: August 19, 2019

25.7K
Models and Methods to Evaluate Transport of Drug Delivery Systems Across Cellular Barriers
18:57

Models and Methods to Evaluate Transport of Drug Delivery Systems Across Cellular Barriers

Published on: October 17, 2013

47.5K
A Choroid Plexus Epithelial Cell-based Model of the Human Blood-Cerebrospinal Fluid Barrier to Study Bacterial Infection from the Basolateral Side
09:58

A Choroid Plexus Epithelial Cell-based Model of the Human Blood-Cerebrospinal Fluid Barrier to Study Bacterial Infection from the Basolateral Side

Published on: May 6, 2016

15.0K

Area of Science:

  • Ophthalmology
  • Cell Biology
  • Pharmacology

Background:

  • The immortalized human corneal epithelial (HCE-T) cell line is extensively used for transcorneal permeability studies.
  • Understanding HCE-T barrier phenotype is crucial for accurate in vitro drug permeation models.

Purpose of the Study:

  • To characterize HCE-T barrier phenotype changes under standardized cultivation conditions.
  • To evaluate how different polycarbonate membrane pore sizes influence HCE-T barrier properties.
  • To determine which HCE-T model best predicts transcorneal drug permeation.

Main Methods:

  • Cultivation of HCE-T cells on polycarbonate membranes with different pore sizes (0.4μm and 3μm).
  • Evaluation of structural and functional barrier properties, including electrical resistance (Ω×cm²).
  • Comparison of drug permeation prediction accuracy between the two models.

Main Results:

  • Two distinct HCE-T barrier phenotypes were identified based on membrane pore size.
  • Model I (0.4μm pores) exhibited a multilayered epithelium with weak barrier function (70-115Ω×cm²).
  • Model II (3μm pores) showed improved barrier properties (1700-2600Ω×cm²) with lipophilic monolayers.

Conclusions:

  • Cultivation conditions significantly impact HCE-T barrier phenotype and function.
  • Model II (3μm pores) demonstrates superior predictive value for ophthalmic drug permeation.
  • Monitoring HCE-T barrier phenotype variability is essential for reliable cell-based models in research.